U.S. scientists say the absence of a specific marker in the blood and tissues of certain monkeys might be part of the key to understanding AIDS resistance.
Tulane University pathologist Ivona Pandrea and colleagues are investigating why monkeys infected for years with simian immunodeficiency virus, the primate version of the human immunodeficiency virus, never develop AIDS.
The team compared blood, lymph nodes and intestines of five primate species that do not develop AIDS when infected with SIV with tissues of species that do develop AIDS as a result of SIV or HIV infection.
She analyzed the presence of CCR5, an important marker found on CD4 cells, which are part of the immune system targeted by HIV and SIV. As the viruses kill the CD4 cells, AIDS develops. CCR5 allows the virus access to those cells.
Pandrea found the AIDS-resistant monkeys had fewer CD4 cells with CCR5 on them than the comparison group. She theorized the absence of CCR5 is due to the adaptation of AIDS-resistant monkeys to SIV infection over millennia, while the others only recently have been exposed to SIV or HIV so they haven't developed resistance.
The study appears in the journal Science.
Copyright 2007 by United Press International
Related stories:
Scientists reveal a protein's role in enabling AIDS virus to reproduce
A team of scientists at Cold Spring Harbor Laboratory (CSHL) has discovered new details about how a simian strain of the AIDS virus replicates. The findings are significant because they suggest new strategies to prevent replication, and because they are applicable to human strains of the virus, which, despite the persistent efforts of scientists over two decades, can only be slowed by drug treatments but neither cured nor prevented.
AIDS may partly be the consequence of an evolutionary accident says scientist
AIDS, a fatal disease in humans, may partly be the consequence of an evolutionary accident, scientists heard today at the Society for General Microbiology’s 162nd meeting being held this week at the Edinburgh International Conference Centre.
Imitating monkey's 'jumping genes' could lead to new treatments for HIV
UCL (University College London) scientists have taken a significant step in understanding how retroviruses such as HIV can move between species and the biological mechanisms behind the ‘jumping genes’ which make some monkeys immune. They will now use this knowledge to develop a gene therapy treatment for HIV/AIDS in humans.
Scientists find rabies-based vaccine could be effective against HIV
Rabies, a relentless, ancient scourge, may hold a key to defeating another implacable foe: HIV. Scientists at Jefferson Medical College in Philadelphia have used a drastically weakened rabies virus to ferry HIV-related proteins into animals, in essence, vaccinating them against an AIDS-like disease. The early evidence shows that the vaccine – which doesn’t protect against infection – prevents development of disease.
HIV gets a makeover: A few adjustments to the AIDS virus could alter the course of research
The slow pace of AIDS research can be pinned, in no small part, on something akin to the square-peg-round-hole conundrum. The HIV-1 virus won’t replicate in monkey cells, so researchers use a monkey virus — known as SIVmac, or the macaque version of simian immunodeficiency virus — to test potential therapies and vaccines in animals. But therapies and vaccines that are effective on SIV don’t necessarily translate into human success.
Viruses Can Jump Between Primates and Humans
Viruses that jump the species barrier between monkeys and humans can harm both people and animals, and we should take steps to reduce the risk of virus transmission. That's the message running through the September issue of the
American Journal of Primatology, a special issue on disease risk analysis edited by a primate expert at the University of Washington.
HIV vaccine might offer survival advantage
U.S. researchers say even if an HIV vaccine doesn't offer perfect protection against the virus, it might provide a survival advantage after infection.
Rectal gel prevents transmission of AIDS-like virus in macaques
The HIV drug tenofovir may prevent AIDS transmission when applied rectally as a gel, according to results from a macaque study published in
PLoS Medicine.